Back to Results
First PageMeta Content
Arthritis / Autoimmune diseases / Rheumatoid arthritis / Biomarker / Anti-citrullinated protein antibody / Disease-modifying antirheumatic drug / Rheumatoid factor / Medicine / Health / Biology


[removed]ETA IS AN EARLY RA BIOMARKER THAT IS MODIFIABLE WITH STANDARD DMARDS AND CORRESPONDS WITH IMPROVEMENT IN CLINICAL VARIABLES 1,* 2
Add to Reading List

Document Date: 2013-07-02 21:51:08

Open Document

File Size: 448,56 KB

Share Result on Facebook

City

Edmonton / Reade / Vancouver / /

Company

Pearson / Augurex Life Sciences Corp / CCP / /

Country

Netherlands / /

Facility

Jan van Breemen Research Institute / /

MedicalCondition

rheumatoid arthritis / disease modifying therapies / /

Organization

ETA / /

Person

Ann Rheum / /

Position

Physician Global Assessment / /

ProvinceOrState

Alberta / /

Technology

antibodies / /

SocialTag